The Federal Trade Commission (FTC) under Chair Lina Khan took an aggressive approach to tackling anticompetitive behavior in ...

The usual PBM strategy cuts an independent pharmacy's share of the prescription revenue to just 3 cents per pill dispensed, ...

Medicare Advantage is currently facing many regulatory challenges under the Democratic Party leadership, including risk adjustments ... though we still see increasing claims concentration in the PBM ...

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

After a preliminary announcement a few weeks ago that included a CEO change, CVS Health CVS released its full third-quarter ...

Nov. 5, 2024 is here. Voters will head to the polls to cast their ballots in the presidential election, shaping the course of ...

My focus has always been on delivering tangible results for my constituents and championing the issues that matter most to them.

Recently, however, a different side of the PBM has begun to emerge -- that of ... likely create situations in which what is best for one party is not best for the other. New and innovative ...

THE LATEST CALLS — DONALD TRUMP wins Arizona, sweeping all seven battleground states. Reps. MARIE GLUESENKAMP PEREZ (D-Wash.) and ELI CRANE (R-Ariz.) win reelection. Maryland Democrat APRIL McCLAIN ...

The results of Tuesday's elections changed control of the White House and the Senate but left the key state-level insurance ...

The recriminations battle is ugly stuff, but it can be almost as important as the election itself: It shapes how we think ...

CVS Health rated Hold, offers dividend yield, facing challenges from CMS decisions and rising medical costs in healthcare ...